Trials / Sponsors / AZTherapies, Inc.
AZTherapies, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairm Ischemic Stroke, Post-stroke Cognitive Impairment | Phase 2 | 2023-12-01 |
| Terminated | A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease Amyotrophic Lateral Sclerosis | Phase 2 | 2020-09-08 |
| Completed | Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Voluntee Healthy Volunteers, Alzheimer Disease | Phase 1 | 2020-08-28 |
| Completed | Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease Alzheimer's Disease | Phase 3 | 2015-09-15 |
| Completed | Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers Healthy Volunteers | Phase 1 | 2015-06-01 |